Dynavax Technologies Corporation (DVAX)

Pretax margin

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before tax but after interest (EBT) (ttm) US$ in thousands 30,856 24,223 18,551 7,852 -4,367 62,611 112,557 237,724 294,299 326,912 234,390 109,489 77,521 -38,533 -5,702 -61,754 -75,240 -96,529 -134,389 -125,523
Revenue (ttm) US$ in thousands 277,247 260,811 249,695 236,149 232,284 361,180 459,401 655,616 722,683 733,261 673,796 470,099 439,442 263,922 169,066 118,967 46,551 37,571 34,732 40,365
Pretax margin 11.13% 9.29% 7.43% 3.33% -1.88% 17.34% 24.50% 36.26% 40.72% 44.58% 34.79% 23.29% 17.64% -14.60% -3.37% -51.91% -161.63% -256.92% -386.93% -310.97%

December 31, 2024 calculation

Pretax margin = EBT (ttm) ÷ Revenue (ttm)
= $30,856K ÷ $277,247K
= 11.13%

Dynavax Technologies Corporation's pretax margin experienced significant fluctuations over the period analyzed. The company demonstrated negative pretax margins in the initial quarters, indicating expenses exceeded revenues. However, a noteworthy turnaround began in the latter part of 2021 and continued into 2024, with pretax margins gradually improving to positive levels. This positive trend suggests that the company may have implemented cost-cutting measures, improved operational efficiency, or experienced revenue growth. The increasing pretax margins indicate a potential enhancement in the company's profitability and financial performance during the latter half of the period.